T1	Participants 123 153	high-risk haematology patients
T2	Participants 257 316	haematology patients at high risk of invasive aspergillosis
T3	Participants 639 773	adults undergoing allogeneic stem-cell transplantation or chemotherapy for acute leukaemia, with no history of invasive fungal disease
T4	Participants 1801 1906	240 eligible patients were recruited from six Australian centres between Sept 30, 2005, and Nov 19, 2009.
T5	Participants 2656 2686	high-risk haematology patients
